CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults... International Academy for Clinical Hematology IACH 35:36 3 years ago 250 Далее Скачать
Cardiotoxicity of CPX-351 vs 7+3 chemotherapy in patients with untreated high-risk AML VJHemOnc – Video Journal of Hematology & HemOnc 1:55 1 year ago 127 Далее Скачать
Risk stratified analysis of CPX-351 versus 7 + 3 in older adults with AML VJHemOnc – Video Journal of Hematology & HemOnc 3:31 3 years ago 47 Далее Скачать
CPX-351 vs 7+3 in older high-risk AML patients VJHemOnc – Video Journal of Hematology & HemOnc 2:29 4 years ago 63 Далее Скачать
Outcomes of CPX-352 vs. 7+3 for t-AML VJHemOnc – Video Journal of Hematology & HemOnc 2:02 4 years ago 105 Далее Скачать
Evaluating CPX-351 against 7+3 in older newly diagnosed AML VJHemOnc – Video Journal of Hematology & HemOnc 5:04 4 years ago 64 Далее Скачать
Liposomal Daunorubicin/Cytarabine for Treatment Naïve AML-MRC and t-AML MedEdOTG 9:51 5 years ago 163 Далее Скачать
Professor Lancet - CPX-351 vs 7+3 in older adults with newly diagnosed, therapy-related AML AML Hub 3:36 7 years ago 64 Далее Скачать
Outcomes in patients with therapy-Related AML who achieved remission with CPX-351 versus 7 plus ... ecancer 6:58 4 years ago 80 Далее Скачать
CPX-351: Phase III trial: Shown Superior 7+3 in Older Patients with ... Oncology.TV 8:10 7 years ago 299 Далее Скачать
CPX-351: Liposomal Cytarabine/Daunorubicin in Secondary AML Targeted Oncology 4:13 5 years ago 264 Далее Скачать
CPX-351: A Potential Game-Changer for Older Patients With Newly Diagnosed Secondary AML? American Society of Hematology 6:26 8 years ago 867 Далее Скачать
Role of CPX-351 in Acute Myeloid Leukemia OncBrothers: Practice-Changing Cancer Discussions 0:54 3 weeks ago 71 Далее Скачать
The current role of CPX-351 in AML and clinical trials evaluating this agent VJHemOnc – Video Journal of Hematology & HemOnc 1:30 1 year ago 106 Далее Скачать
